278 related articles for article (PubMed ID: 10901233)
1. Radiation-induced meningioma: a distinct molecular genetic pattern?
Shoshan Y; Chernova O; Juen SS; Somerville RP; Israel Z; Barnett GH; Cowell JK
J Neuropathol Exp Neurol; 2000 Jul; 59(7):614-20. PubMed ID: 10901233
[TBL] [Abstract][Full Text] [Related]
2. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
3. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
Gutmann DH; Donahoe J; Perry A; Lemke N; Gorse K; Kittiniyom K; Rempel SA; Gutierrez JA; Newsham IF
Hum Mol Genet; 2000 Jun; 9(10):1495-500. PubMed ID: 10888600
[TBL] [Abstract][Full Text] [Related]
4. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
5. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
Nunes F; Shen Y; Niida Y; Beauchamp R; Stemmer-Rachamimov AO; Ramesh V; Gusella J; MacCollin M
Cancer Genet Cytogenet; 2005 Oct; 162(2):135-9. PubMed ID: 16213361
[TBL] [Abstract][Full Text] [Related]
6. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
[TBL] [Abstract][Full Text] [Related]
10. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.
Maxwell M; Shih SD; Galanopoulos T; Hedley-Whyte ET; Cosgrove GR
J Neurosurg; 1998 Mar; 88(3):562-9. PubMed ID: 9488313
[TBL] [Abstract][Full Text] [Related]
11. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
[TBL] [Abstract][Full Text] [Related]
12. Allelic losses in neurofibromatosis 2-associated meningiomas.
Lamszus K; Vahldiek F; Mautner VF; Schichor C; Tonn J; Stavrou D; Fillbrandt R; Westphal M; Kluwe L
J Neuropathol Exp Neurol; 2000 Jun; 59(6):504-12. PubMed ID: 10850863
[TBL] [Abstract][Full Text] [Related]
13. Deletion mapping of the long arm of chromosome 22 in human meningiomas.
Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I
Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212
[TBL] [Abstract][Full Text] [Related]
14. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas.
Agnihotri S; Suppiah S; Tonge PD; Jalali S; Danesh A; Bruce JP; Mamatjan Y; Klironomos G; Gonen L; Au K; Mansouri S; Karimi S; Sahm F; von Deimling A; Taylor MD; Laperriere NJ; Pugh TJ; Aldape KD; Zadeh G
Nat Commun; 2017 Aug; 8(1):186. PubMed ID: 28775249
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of schwannomin/merlin in human sporadic meningiomas.
Lee JH; Sundaram V; Stein DJ; Kinney SE; Stacey DW; Golubić M
Neurosurgery; 1997 Mar; 40(3):578-87. PubMed ID: 9055299
[TBL] [Abstract][Full Text] [Related]
18. Lack of genetic and epigenetic changes in meningiomas without NF2 loss.
van Tilborg AA; Morolli B; Giphart-Gassler M; de Vries A; van Geenen DA; Lurkin I; Kros JM; Zwarthoff EC
J Pathol; 2006 Mar; 208(4):564-73. PubMed ID: 16353169
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
